Literature DB >> 8319221

DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.

R Smaaland1, K Lote, R B Sothern, O D Laerum.   

Abstract

Significant circadian cell cycle variations with a maximal number of cells in S-phase during the night have been found in a series of 24 patients (18 men and 6 women) with histologically established non-Hodgkin's lymphomas. Pathological lymph nodes of a total of 26 patients were punctured and aspirated by fine needle technique every 4 h during a single 24-h time span. Twenty-four patients (92.3%) had Stage III or IV disease. Twelve patients (46.1%) had low grade, 10 patients (38.5%) had intermediate grade, and 4 patients (15.4%) had high grade lymphomas according to the Working Formulation. The samples were analyzed by flow cytometry, and DNA synthesis (S-phase) and ploidy were determined according to circadian stage. The individual mean 24-h S-phase varied from 2.2 +/- 1.2% (mean +/- SD) to 24.0 +/- 3.3%. Within the group of patients with low grade lymphomas, a wide range in mean S-phase from 2.4 +/- 1.2% to 9.2 +/- 2.8% was observed. The percentage variation within each patient between the lowest and highest S-phase as compared to the lowest value (range of change) during the 24-h time span varied from 21 to 353%, with a mean range of change of 128 +/- 19%. When each individual S-phase series was converted to percent of mean and combined for analysis by one-way analysis of variance to test for time-effect across 2 12-h time spans (8 p.m.-8 a.m. versus 8 a.m.-8 p.m.), S-phase variation according to circadian stage was found to be statistically significant (P < 0.004), with higher values found in the 8 p.m.-8 a.m. time span. By single cosinor analysis, S-phase yielded a near significant P value of 0.069 for the least-squares fit of a 24-h cosine to all data as percent of mean, with the acrophase found to be near midnight (0.05 h). For those patients with low and intermediate grade lymphomas and with mean S-phase values < 10.0%, we found that mean S-phase was higher during winter (5.8 +/- 0.4%) than during spring (3.8 +/- 0.3%) or during fall (3.6 +/- 0.3%) (P < 0.001, analysis of variance). Twenty-one of the 26 patients (80.8%) had an aneuploid, hypodiploid, or near diploid population in one or several of the repeated samples. For the whole series, the DNA indices for the aneuploid populations varied from 1.09 to 1.96, the median DNA index being 1.20.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319221

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Replication synchrony-PCR: a sampling-time-independent assay for replication synchrony in human tissues and tumors in situ.

Authors:  L De Francesco; R R Klevecz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Modeling the Influence of Seasonal Differences in the HPA Axis on Synchronization of the Circadian Clock and Cell Cycle.

Authors:  Kamau Pierre; Rohit T Rao; Clara Hartmanshenn; Ioannis P Androulakis
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

3.  Circadian gene mPer2 overexpression induces cancer cell apoptosis.

Authors:  Hui Hua; Yueqi Wang; Chaomin Wan; Yanyou Liu; Bin Zhu; Chunlei Yang; Xiaojia Wang; Zhengrong Wang; Germaine Cornelissen-Guillaume; Franz Halberg
Journal:  Cancer Sci       Date:  2006-07       Impact factor: 6.716

4.  Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Derek Leaderer; Carly Guss; Heather N Brown; Yawei Zhang; Peter Boyle; Richard G Stevens; Aaron Hoffman; Qin Qin; Xuesong Han; Tongzhang Zheng
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

Review 5.  Metabolism and cancer: the circadian clock connection.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 6.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patients.

Authors:  G A Bjarnason; I G Kerr; N Doyle; M Macdonald; M Sone
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Clock-cancer connection in non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Tongzhang Zheng
Journal:  Med Hypotheses       Date:  2007-11-01       Impact factor: 1.538

9.  Seasonal variations in the presentation and growth of thyroid cancer.

Authors:  L A Akslen; R B Sothern
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Variation of growth rate of a rat tumour during a light-dark cycle: correlation with circadian fluctuations in tumour blood flow.

Authors:  K Hori; Q H Zhang; H C Li; S Saito
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.